EUVIMEDEUVIMED entdecken
Crossref

Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment

Qixin Zhao iD, Rui Zeng, Tao Bi, Xuemei Yang, Ting Wang, Lei Chen, Juan Huang, Xiyu Dai, Houping Xu, Qin Sun, Zengjin Liu iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c18202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Qixin Zhao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Drug Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical …. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Deoxycytidine, Prodrugs. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Southwest Medical University, Sichuan Provincial Administration of Traditional Chinese Medicine, Sichuan Provincial Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsDeoxycytidineProdrugsAntineoplastic AgentsHumansGemcitabineAnimalsMiceProteolysisCell Cycle ProteinsCell Line, TumorTranscription FactorsApoptosisMice, NudeXenograft Model Antitumor AssaysCell ProliferationProteolysis Targeting ChimeraBromodomain Containing Proteins

Stichwörter der Autor:innen

BT-GEM/MZ1@NPGEMMZ1NSCLCcancercellferroptosistherapeutictumor

Substanzen

DeoxycytidineGemcitabineBRD4 protein, humanProdrugsCell Cycle ProteinsAntineoplastic AgentsTranscription FactorsProteolysis Targeting ChimeraBromodomain Containing Proteins

Autor:innen und Institutionen

  • Drug Research Center of Integrated Traditional Chinese and Western Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, Sichuan, China.
  • Department of Emergency Medicine, Fushun People's Hospital, Zigong 643000, China.
  • Luzhou Key Laboratory of Research and Development of Medical Institution Preparations and Large-Scale Health Products, Luzhou 646000, Sichuan, China.
  • Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou 646000, Sichuan, China.

ORCID-Profile: Qixin Zhao, Zengjin Liu

Förderung

  • Southwest Medical University
  • Sichuan Provincial Administration of Traditional Chinese Medicine
  • Sichuan Provincial Science and Technology Support Program

Zitieren

APA

Zhao, Q., Zeng, R., Bi, T., Yang, X., Wang, T., Chen, L., Huang, J., Dai, X., Xu, H., Sun, Q., & Liu, Z. (2025). Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c18202

Vancouver

Zhao Q, Zeng R, Bi T, Yang X, Wang T, Chen L, et al. Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c18202

BibTeX
@article{Zhao2025,
  author = {Zhao, Qixin and Zeng, Rui and Bi, Tao and Yang, Xuemei and Wang, Ting and Chen, Lei and Huang, Juan and Dai, Xiyu and Xu, Houping and Sun, Qin and Liu, Zengjin},
  title = {Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer Treatment},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c18202}
}
Kostenlos starten →